A detailed immunohistochemical analysis of 2 cases of papillary cystadenoma of the broad ligament: An extremely rare neoplasm characteristic of patients with von Hippel-Lindau disease

International Journal of Gynecological Pathology

Volumn 31, Issue 2, 2012, Pages 133-140

  Brady, Aidan ^a   Nayar, Anitha ^b   Cross, Paul ^b   Patel, Amit ^b   Naik, Raj ^b   Lee, Susan ^c   Kaushik, Sonali ^c   Barton, Des ^c   McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Immunohistochemistry; Lindau disease; Papillary cystadenoma; Von Hippel

Indexed keywords

ANDROGEN RECEPTOR; CA125 ANTIGEN; CALRETININ; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 1BETA; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; VIMENTIN; VON HIPPEL LINDAU PROTEIN;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BLEEDING; BROAD LIGAMENT; BROAD LIGAMENT PAPILLARY CYSTADENOMA; CASE REPORT; CYSTADENOMA; CYTOPLASM; ECHOGRAPHY; ENDOMETRIOSIS; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER ABDOMINAL PAIN; MUELLER CELL; OMENTUM; POSTMENOPAUSE; PRIORITY JOURNAL; RARE DISEASE; SALPINGOOOPHORECTOMY; VON HIPPEL LINDAU DISEASE;

BROAD LIGAMENT; CYSTADENOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; VON HIPPEL-LINDAU DISEASE;

EID: 84863118581     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318228f577     Document Type: Article

References (28)

1. Hes FJ, van der Luijt RB, Lips CJ. Clinical management of Von Hippel-Lindau (VHL) disease. Neth J Med 2001;59: 225-234. (Pubitemid 33036849)
2. Singh AD, Shields CL, Shields JA. Von Hippel-Lindau disease. Surv Opthalmol 2001;46:117-142. (Pubitemid 32913484)
3. Werness BA, Guccion JG. Tumor of the broad ligament in von Hippel-Lindau disease of probable mullerian origin. Int J Gynecol Pathol 1997;16:282-285. (Pubitemid 27282304)
4. Aydin H, Young RH, Ronnett BM, et al. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma. Am J Surg Pathol 2005;29:520-523. (Pubitemid 40411186)
5. Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumour of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease. Am J Surg Pathol 1994;18:1254-1260. (Pubitemid 24362439)
6. Zanotelli DB, Bruder E, Wight E, et al. Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of von Hippel-Lindau disease. Arch Gynecol Obstet 2010;282: 343-346.
7. Korn WT, Schatzki SC, DiSciullo AJ, et al. Papillary cystadenoma of the broad ligament in von Hippel-Lindau disease. Am J Obstet Gynecol 1990;163:596-598. (Pubitemid 20287641)
8. Gersell DJ, King TC. Papillary Cystadenoma of the mesosalpinx in von Hippel-Lindau disease. Am J Surg Pathol 1988;12:145-149. (Pubitemid 18052948)
9. Zanotelli DB, Bruder E, Wight E, et al. Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of Von Hippel-Lindau disease. Arch Gynecol Obstet 2010;282:343-346.
10. Funk KC, Heiken JP. Papillary cystadenoma of the broad ligament in a patient with von Hippel-Lindau disease. AJR 1989;153:527-528. (Pubitemid 19210752)
11. Shen T, Zhuang Z, Gersell DJ, et al. Allelic deletion of VHL gene detected in papillary tumours of the broad ligament, epididymis, and retroperitoneum in von Hippel-Lindau disease patients. Int J Surg Pathol 2000;8:207-212.
12. Wernert R, Goebbels R, Prediger L. Papillary cystadenoma of the epididymis: case report and review of the literature. Pathol Res Pract 1986;181:260-262.
13. McCluggage WG, Oliva E, Herrington CS, et al. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003;43:144-150. (Pubitemid 36963158)
14. Ordi J, Nogales FF, Palacin A, et al. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol 2001;25: 1540-1545. (Pubitemid 33096970)
15. Oliva E. C 10 expression in the female genital tract: does it have useful diagnostic applications? Adv Anat Pathol 2004 11 310-315
16. Silver SA, Devouassoux-Shisheboran M, Mezzetti TP, et al. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings. Am J Surg Pathol 2001;25:379-387. (Pubitemid 32174207)
17. Tiltman AJ, Allard U. Female adnexal tumours of probable Wolffian origin: an immunohistochemical study comparing tumours, mesonephric remnants and paramesonephric derivatives. Histopathology 2001;38:237-242. (Pubitemid 32862734)
18. Devouassoux-Shisheboran M, Silver SA, Tavassoli FA. Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin. Hum Pathol 1999;30:856-863. (Pubitemid 29325794)
19. Laury AR, Hornick JL, Perets R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol 2010;34:627-635.
20. Tong GX, Yu WM, Beaubier NT, et al. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol 2009;22:1218-1227.
21. Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 2008;32:1566-1571.
22. Tong GX, Weeden EM, Hamele-Bena D, et al. Expression of PA 8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract:evidence of related histogenesis? Am J Surg Pathol 2008 32 1380-1387.
23. Kobel M, Kalloger SE, Carrick J, et al. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol 2009;33:14-21.
24. Yamamoto S, Tsuda H, Aida S, et al. Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium. Hum Pathol 2007;38:1074-1080. (Pubitemid 46899152)
25. Cameron RI, Ashe P, O'Rourke DM, et al. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Int J Gynecol Pathol 2003;22:272-276. (Pubitemid 36750410)
26. Zbar B, Brauch H, Talmadge C, et al. Loss of alleles of loci on the short arm of chromosome 3 associated with renal cell carcinoma. Nature 1988;332:268-269.
27. Anglard P, Tory K, Brauch H, et al. Molecular analysis of genetic changes in the origin and development of renal carcinoma. Cancer Res 1991;15:1071-1077.
28. Vortmeyer MO, Gnarra JR, Emmert-Buck MR, et al. VHL gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel- Lindau disease. Hum Pathol 1997;28:540-543. (Pubitemid 27213049)